Coherus Biosciences | CHRS - 市值



金融业
股票价格
USD
资产
USD 191.18M
现金及等价物
USD 82.92M
销售成本
USD 4.05M
流动资产
USD 133.79M
流动负债
USD 75.51M
债务
USD 294.93M
股息收益率
0
EBIT
USD -39.08M
EBITDA
USD -43.33M
员工
306
EPS每股收益
USD -0.43
股本和储备
USD 60.84M
销售毛利
USD 8.7M
债务利息支出
USD 2.25M
贷款资金
USD 51.08M
市值
USD 153.3M
净收入
USD -37.64M
营业费用
USD 51.83M
营业利润
USD -39.08M
普通股股本
USD 121.16M
税前利润
USD -46.35M
销售收入
USD 12.75M
销售和管理费用
USD 15M
股票
USD 5.67M
贸易债权人
USD 13.17M
应收帐款人
USD 18.42M


市值 更改 日
AbbVie USD 435.86B 8.73B 2026-08
Acadia Pharmaceuticals USD 4.53B 199M 2026-08
Akebia Therapeutics USD 427M 297M 2025-12
ALKERMES USD 7.93B 806M 2026-08
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amarin USD 290M 51M 2025-12
Amgen USD 209.65B 14.21B 2026-08
Baxter International USD 11.01B 2.34B 2026-06
Biogen USD 31.9B 5B 2026-06
BioMarin Pharmaceutical USD 11.71B 651M 2026-08
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Coherus Biosciences USD 172M 19M 2025-12
Eli Lilly USD 1.11T 18.32B 2026-08
Fujifilm JPY 3.69T 340.04B 2026-03
Gilead Sciences USD 168.68B 11.82B 2026-08
Merck USD 324.18B 6.81B 2026-08
Pacira USD 1.28B 286M 2026-08
Perrigo USD 1.45B 135M 2026-08
Pfizer USD 153.17B 14.73B 2026-08
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Sarepta Therapeutics USD 1.5B 402M 2026-08
Teva Pharmaceutical Industries USD 114.54B 80.27B 2026-06
Vertex Pharmaceuticals USD 137.33B 11.26B 2026-08
Xencor USD 1.21B 19M 2026-08
Zoetis USD 35.38B 5.25B 2026-08